CMS may consider suppressing Overall Hospital Quality Star Rating for subsection (d) hospitals only under extenuating circumstances that affect numerous hospitals (as in, not an individualized or localized issue) as determined by CMS, or when CMS is at fault, including but not limited to when: (i) There is an Overall Hospital Quality Star Rating calculation error by CMS
When to modify or discontinue peptide therapy Continue indicators: Stable disease vs historical progression, measurable improvements in objective testing, good tolerability without significant side effects, financial sustainability, patient satisfaction with outcomes
Consultation First, have a detailed discussion with your clinician
Compounded medications explained Belle is clear that compounded GLP-1 and GLP-1/GIP are not FDA-approved
The SARS-CoV-2 infection could reach the brainstem and inflict cerebral lesions as long-term sequelae with several neuro-cognitive dysfunctions in PASC patients